NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK)
Post# of 126
(Total Views: 611)
Posted On: 12/03/2020 4:58:23 PM
NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Positive Clinical Study Results for ‘HERHEART(TM)’
Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of clinically proven cardiovascular and neuro products, today announced that the newly released clinical study of BergaMet NA’s HERHEART(TM) product produced incredible results. In addition, the company announced the appointment of internationally renowned Dr. Nesochi Okeke-Igokwe MD., M.S to its medical advisory board to promote women’s health. “Cardiovascular disease is the number one cause of death for women in the United States,” said Duke Pitts, CEO of BergaMet NA. “HERHEART was specifically formulated to fill the void in heart health products specifically designed for women. Not only does HERHEART assist in metabolic syndrome challenges, it also provides continued support for women as they mature. There is no other product that focuses directly on women, combines natural ingredients, and has the clinical studies to confirm its effectiveness. We expect HERHEART to become one of our top selling products as it provides an exclusive market position.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of clinically proven cardiovascular and neuro products, today announced that the newly released clinical study of BergaMet NA’s HERHEART(TM) product produced incredible results. In addition, the company announced the appointment of internationally renowned Dr. Nesochi Okeke-Igokwe MD., M.S to its medical advisory board to promote women’s health. “Cardiovascular disease is the number one cause of death for women in the United States,” said Duke Pitts, CEO of BergaMet NA. “HERHEART was specifically formulated to fill the void in heart health products specifically designed for women. Not only does HERHEART assist in metabolic syndrome challenges, it also provides continued support for women as they mature. There is no other product that focuses directly on women, combines natural ingredients, and has the clinical studies to confirm its effectiveness. We expect HERHEART to become one of our top selling products as it provides an exclusive market position.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)